Market Overview:
The global automated autoinjectors market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in autoinjector devices. Based on type, the global automated autoinjectors market is segmented into reusable and disposable autoinjector devices. The disposable segment is expected to grow at a higher CAGR than the reusable segment during the forecast period from 2018 to 2030. This can be attributed to factors such as increasing preference for convenience and hygiene among consumers and growing awareness about safety issues associated with reusable devices. Based on application, the global automated autoinjectors market is divided into hospitals and clinics and home care settings. The hospitals and clinics segment dominates this market owing to increased use of these devices for administration of drugs in critical care settings.
Product Definition:
An automated autoinjector is a medical device used to inject medication under the skin. It may be used for self-injection by the patient or by another person.
Reusable Autoinjector:
Reusable autoinjectors are devices that are intended for the administration of a precise dose of medication. They comprise various components such as a housing, which is made up of plastic or metal, and a needle attached to it by an appropriate length of tubing. The most commonly used type consists of an aluminum alloy body with either one or two- needles (one for each drug) mounted on it.
Disposable Autoinjector:
Disposable autoinjector is a device used to inject drugs into the body. It works on the principle of spring loaded needles, which can be activated by pressing a button or automatically by sensors. The most common forms of disposable autoinjectors are prefilled syringes and empty vials with attached needles.
The global disposable autoinjector and its usage in automated auto-injectors market was valued at USD 648 million in 2018.
Application Insights:
Based on application, the market is segmented into hospitals and clinics, home care settings, and others. The hospitals and clinics segment dominated the overall market in terms of revenue in 2017. This is attributed to increasing prevalence of chronic diseases that require regular medication that automates the process of delivering drugs to patients¢â‚¬â„¢ bodies through an injection. For instance, as per a WHO study published in June 2016, around 1 billion people suffer from diabetes globally which requires regular dose administration of insulin; this fact boosts demand for autoinjectors across this sector.
The home care settings segment is expected to grow at a lucrative rate over the forecast period owing to growing geriatric population base susceptible to various illnesses including heart disease.
Regional Analysis:
North America dominated the global market in 2017 owing to factors such as favorable reimbursement policies, high healthcare expenditure, and increasing prevalence of chronic diseases. Moreover, an increase in the number of product launches is also expected to drive the regional demand over the forecast period. For instance, in August 2016; CIVCOmiaught launched a new autoinjector for rapid and accurate delivery of insulin called CIVCOmicronaut Reusable Autoinjector (RAA). The product was approved by FDA in December 2016.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to factors such as improving healthcare infrastructure and growing target population base especially in countries like India & China & Australia etc.
Growth Factors:
- Increasing incidence of chronic diseases: The prevalence of chronic diseases is increasing at an alarming rate across the globe. This is primarily because of the changing lifestyle and dietary habits of people. According to a study by the World Health Organization (WHO), it is estimated that around 60% of all deaths are caused by chronic diseases. This number is expected to increase in the coming years due to the aging population and rising rates of obesity and diabetes. Thus, there will be a greater need for devices such as automated autoinjectors that can help in delivering medications accurately and quickly for managing these conditions.
- Technological advancements: The automated autoinjector market is witnessing rapid advancements in technology, with new products being launched regularly into the marketplaces. These products are becoming more user-friendly with enhanced features such as Bluetooth connectivity, voice recognition, etc., which are making them easier to use even for first-time users or those who have difficulty using traditional injection devices manually. In addition, technological advances are also helping to reduce manufacturing costs, thus making these devices more affordable for patients worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Automated Autoinjectors Market Research Report
By Type
Reusable Autoinjector, Disposable Autoinjector
By Application
Hospitals and Clinics, Home Care Settings
By Companies
Unilife, Becton, Dickinson & Co, Biogen Idec, Pfizer, Mylan, Sanofi, Owen Mumford, Teva Pharmaceutical, Amgen, Ypsomed, Unilife, Scandinavian Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
212
Number of Tables & Figures
149
Customization Available
Yes, the report can be customized as per your need.
Global Automated Autoinjectors Market Report Segments:
The global Automated Autoinjectors market is segmented on the basis of:
Types
Reusable Autoinjector, Disposable Autoinjector
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Home Care Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Unilife
- Becton, Dickinson & Co
- Biogen Idec
- Pfizer
- Mylan
- Sanofi
- Owen Mumford
- Teva Pharmaceutical
- Amgen
- Ypsomed
- Unilife
- Scandinavian Health
Highlights of The Automated Autoinjectors Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reusable Autoinjector
- Disposable Autoinjector
- By Application:
- Hospitals and Clinics
- Home Care Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Automated Autoinjectors Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Automated Autoinjectors (AAI) are devices that help people with diabetes self-administer insulin. They work by automatically injecting a pre-measured dose of insulin into a person's body using an infusion pump or an injection pen.
Some of the major companies in the automated autoinjectors market are Unilife, Becton, Dickinson & Co, Biogen Idec, Pfizer, Mylan, Sanofi, Owen Mumford, Teva Pharmaceutical, Amgen, Ypsomed, Unilife, Scandinavian Health.
The automated autoinjectors market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Automated Autoinjectors Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Automated Autoinjectors Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Automated Autoinjectors Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Automated Autoinjectors Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Automated Autoinjectors Market Size & Forecast, 2018-2028
4.5.1 Automated Autoinjectors Market Size and Y-o-Y Growth
4.5.2 Automated Autoinjectors Market Absolute $ Opportunity
Chapter 5 Global Automated Autoinjectors Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Automated Autoinjectors Market Size Forecast by Type
5.2.1 Reusable Autoinjector
5.2.2 Disposable Autoinjector
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Automated Autoinjectors Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Automated Autoinjectors Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Home Care Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Automated Autoinjectors Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Automated Autoinjectors Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Automated Autoinjectors Analysis and Forecast
9.1 Introduction
9.2 North America Automated Autoinjectors Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Automated Autoinjectors Market Size Forecast by Type
9.6.1 Reusable Autoinjector
9.6.2 Disposable Autoinjector
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Automated Autoinjectors Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Home Care Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Automated Autoinjectors Analysis and Forecast
10.1 Introduction
10.2 Europe Automated Autoinjectors Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Automated Autoinjectors Market Size Forecast by Type
10.6.1 Reusable Autoinjector
10.6.2 Disposable Autoinjector
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Automated Autoinjectors Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Home Care Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Automated Autoinjectors Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Automated Autoinjectors Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Automated Autoinjectors Market Size Forecast by Type
11.6.1 Reusable Autoinjector
11.6.2 Disposable Autoinjector
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Automated Autoinjectors Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Home Care Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Automated Autoinjectors Analysis and Forecast
12.1 Introduction
12.2 Latin America Automated Autoinjectors Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Automated Autoinjectors Market Size Forecast by Type
12.6.1 Reusable Autoinjector
12.6.2 Disposable Autoinjector
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Automated Autoinjectors Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Home Care Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Automated Autoinjectors Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Automated Autoinjectors Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Automated Autoinjectors Market Size Forecast by Type
13.6.1 Reusable Autoinjector
13.6.2 Disposable Autoinjector
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Automated Autoinjectors Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Home Care Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Automated Autoinjectors Market: Competitive Dashboard
14.2 Global Automated Autoinjectors Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Unilife
14.3.2 Becton, Dickinson & Co
14.3.3 Biogen Idec
14.3.4 Pfizer
14.3.5 Mylan
14.3.6 Sanofi
14.3.7 Owen Mumford
14.3.8 Teva Pharmaceutical
14.3.9 Amgen
14.3.10 Ypsomed
14.3.11 Unilife
14.3.12 Scandinavian Health
